Core Viewpoint - Meikang Bio (300439.SZ) has recently obtained the Medical Device Registration Certificate for in vitro diagnostic reagents from the National Medical Products Administration and Zhejiang Provincial Medical Products Administration, which includes the hepatitis B virus e antibody detection kit and the Golgi protein 73 detection kit [1] Group 1 - The company has received regulatory approval for two diagnostic kits [1] - The approved products utilize chemiluminescent microparticle immunoassay technology [1]

Group 1 - The company, Meikang Bio (300439.SZ), has recently obtained the Medical Device Registration Certificate for in vitro diagnostic reagents from the National Medical Products Administration and the Zhejiang Provincial Drug Administration [1] - The registered products include the hepatitis B virus e antibody detection kit (chemiluminescent microparticle immunoassay) and the Golgi protein 73 detection kit (chemiluminescent microparticle immunoassay) [1]